Frank Haluska is the founder of Kestrel Therapeutics. Kestrel Therapeutics has raised $13M in total funding. Latest round: Series A.
Frank Haluska is the founder of Kestrel Therapeutics, a biotechnology startup established in 2020. He launched the company with a RAS asset from his previous venture, Anchiano Therapeutics, and has secured early funding from investors such as Pfizer Ventures and Santé Health Ventures. Haluska leads Kestrel Therapeutics and has overseen two funding rounds.
Full founder directory · Investor directory · Company funding database · Fundraising library